Hedge Fund and Insider Trading News: Howard Marks, Ray Dalio, Eisler Capital, King Street Capital Management, SkyBridge Capital, Ault Global Holdings Inc (DPW), BioVaxys Technology (BVAXF), and More

Page 2 of 2

Hedge Fund Assets Near USD4 Trillion as Fresh Inflation Fears Push Investors Towards Alternatives (Hedge Week)
Growing numbers of investors are turning to hedge funds to protect their portfolios in the face of inflationary fears, with total industry capital swelling to almost USD4 trillion and more allocators set to tilt towards alternative assets, new research shows. Alternatives technology provider Vidrio Financial’s latest allocator market survey suggests inflation fears during the first half of 2021 are driving further allocations to alternative asset classes, such as hedge funds and private equity, which have historically outperformed equities and bonds during periods of inflation. The Vidrio Financial Allocator Market Survey quizzed some 4,500 institutional investors globally in late June, collectively representing USD100 billion in assets under management and split roughly 60/40 between North America and EMEA.

Legendary Investor Howard Marks Thinks We are at the Bull Market Stage Where ‘People Tend to Accept the Trees will Grow to the Sky.’ He Explains Why Studying Psychology Gives Investors ‘a Great Advantage’ and why it’s Important to Deviate from the Crowd. (Business Insider)
Howard Marks is known as somewhat of a philosopher king in the world of investing. The co-chairman of the $153 billion Oaktree Capital Management has not only built the world’s largest distressed-debt investment firm but also penned 132 iconic memos since 1990.

Investing in the Elderly: A Primer (Preqin)
As the investment thesis surrounding aging and elderly populations gains traction, we explore its foundations and mediums of implementation. Aging is a fact of life. We’re all growing older – some of us for the better, some for the worse. Increasingly, when and how we age is attracting the attention of everyone from policymakers to scientists and investors.

SkyBridge Co-CIO Troy Gayeski Resigns (Opalesque)
Troy Gayeski has resigned from SkyBridge Capital, where he was a Partner, Co-CIO, and Senior Portfolio Manager. No details about his future plans are available as of this writing. Gayeski joined SkyBridge in 2010 when SkyBridge acquired Citigroup Alternative Investments’ fund-of-funds business. He served as Senior Portfolio Manager until February 2019, when he was elevated to Co-Chief Investment Officer alongside Ray Nolte.

Thursday 7/22 Insider Buying Report: DPW, TCRX (Nasdaq.com)
On Tuesday, Ault Global Holdings’ Executive Chairman, Milton C. Ault III, made a $45,622 purchase of DPW, buying 20,000 shares at a cost of $2.28 a piece. Ault III was up about 8.3% on the buy at the high point of today’s trading session, with DPW trading as high as $2.47 in trading on Thursday. Ault Global Holdings is trading off about 1.5% on the day Thursday. Before this latest buy, Ault III purchased DPW on 3 other occasions during the past twelve months, for a total investment of $9,491 at an average of $3.80 per share. And also on Tuesday, Chief Financial Officer Brian M. Silver purchased $15,000 worth of Tscan Therapeutics, purchasing 1,000 shares at a cost of $15.00 each. Tscan Therapeutics is trading down about 2.2% on the day Thursday. Bargain hunters have the opportunity to grab TCRX even cheaper than Silver did, with shares trading as low as $9.64 at last check today which is 35.7% below Silver’s purchase price.

The Executive of BioVaxys Technology (Other OTC: BVAXF) is Buying Shares (Analyst Ratings)
Today, the Executive of BioVaxys Technology (BVAXF), James Passin, bought shares of BVAXF for $50.6K. This is Passin’s first transaction since reporting a Buy transaction on UTOLF back in April 2020 This recent transaction increases James Passin’s holding in the company by 2% to a total of $2.43 million. Currently, BioVaxys Technology has an average volume of 13.82K. The company has a one-year high of $0.62 and a one-year low of $0.05.

Facebook Inc (FB) COB and CEO Mark Zuckerberg Sold $26 million of Shares (Guru Focus)
COB and CEO of Facebook Inc, Mark Zuckerberg, sold 77,300 shares of FB on 07/19/2021 at an average price of $336.63 a share. The total sale was $26 million.


Page 2 of 2